Controversies in preoperative therapy in esophageal cancer: Current evidence and ongoing research
Abstract Esophageal cancer incidence is growing worldwide, especially adenocarcinomas in the western world. Outcomes overall are universally poor, with the best survival seen in earlier stages of the disease, where surgery is the mainstay of treatment. Although squamous cell cancers and adenocarcino...
Main Authors: | Apurva Ashok, Virendra Tiwari, Sabita Jiwnani, George Karimundackal, C. S. Pramesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Annals of Gastroenterological Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ags3.12301 |
Similar Items
-
Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
by: Guozhen Yang, et al.
Published: (2024-05-01) -
Surgical outcomes of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in patients of locally advanced carcinoma of esophagus: A prospective cross-sectional comparative study
by: Rohit Kumar Jha, et al.
Published: (2024-02-01) -
Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: A systematic review and meta-analysis
by: He Wang, et al.
Published: (2022-09-01) -
Therapeutic evaluation of postoperative chemotherapy and chemoradiotherapy on cardiopulmonary complications in patients with esophageal squamous cell carcinoma
by: Gustavo Martins Aransiola, et al.
Published: (2023-07-01) -
How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?
by: Yusuke Taniyama, et al.
Published: (2019-04-01)